DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection
Condition(s):HIV-1-infectionLast Updated:January 12, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):HIV-1-infectionLast Updated:January 12, 2024Not yet recruiting
Condition(s):HIV-1-infectionLast Updated:March 12, 2024Recruiting
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionsLast Updated:March 4, 2024Not yet recruiting
Condition(s):Acute HIV InfectionLast Updated:February 15, 2023Recruiting
Condition(s):HIV InfectionLast Updated:April 6, 2023Recruiting
Condition(s):Multi-Drug Resistant Hiv-1 Infection; HIV-1 InfectionLast Updated:September 18, 2023Recruiting
Condition(s):Monkey Pox; HIV InfectionsLast Updated:June 28, 2023Not yet recruiting
Condition(s):Recent HIV-1 InfectionLast Updated:March 6, 2024Recruiting
Condition(s):Acute HIV InfectionLast Updated:February 23, 2024Not yet recruiting
Condition(s):HIV InfectionsLast Updated:December 26, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.